what's going to happen on monday, page-11

yes, well, so many possibilities at this point.

i guess the most likely candidate is the licensing deal with tacere reaching another milestone. the minimum 12 month fully funded toxicology studies should be completed around february.

presumably the recent trend reversal, if not in anticipation of a takeover or other acquisition, is at least an indication of positive results being achieved here, which is yet another endorsment of the massive potential of the technology.

also, BLTOA remains an outside chance. at 15c, BLT would become an $80m company with $8m in cash, enough to see them through for quite some time.

one decent deal is probably all it would take to see those sort of prices again.

the market is flush with rerates of late, anything is possible